Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Review

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

         
Total article views   Abstract views HTML views PDF downloads Totals
11,901 Dovepress* 7,322 706+ 2,137 8,028
PubMed Central* 0 3,873 486 3,873
Totals 7,322 4,579 2,623 11,901
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar